|
US443459A
(en)
|
|
1890-12-23 |
|
Clarence l |
|
FR640907A
(fr)
|
1927-06-25 |
1928-07-24 |
|
Limitateur de débit automatique
|
|
US2168437A
(en)
|
1935-04-10 |
1939-08-08 |
Kenneth O Buercklin |
Injection device
|
|
US2133073A
(en)
|
1935-12-30 |
1938-10-11 |
Manning Maxwell & Moore Inc |
Method of and apparatus for controlling pressure fluid
|
|
US2110208A
(en)
|
1937-02-12 |
1938-03-08 |
U S Standard Products Company |
Antigen preparations
|
|
US2531724A
(en)
|
1948-09-20 |
1950-11-28 |
Edmund D Cevasco |
Infant bath mat
|
|
US3025991A
(en)
|
1960-05-23 |
1962-03-20 |
Carron Products Co |
Bottle stopper
|
|
NL137652C
(enExample)
|
1962-07-11 |
|
|
|
|
GB1049104A
(en)
|
1963-05-11 |
1966-11-23 |
Prodotti Antibiotici Spa |
Pharmaceutical compositions for oral or parenteral administration comprising tetracycline antibiotics
|
|
US3122162A
(en)
|
1963-06-20 |
1964-02-25 |
Asa D Sands |
Flow control device
|
|
BE744162A
(fr)
|
1969-01-16 |
1970-06-15 |
Fuji Photo Film Co Ltd |
Procede d'encapsulage
|
|
US3632768A
(en)
|
1969-10-02 |
1972-01-04 |
Upjohn Co |
Therapeutic composition and method for treating infections with actinospectacin
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
DE2010115A1
(de)
|
1970-03-04 |
1971-09-16 |
Farbenfabriken Bayer Ag, 5090 Leverkusen |
Verfahren zur Herstellung von Mikrogranulaten
|
|
US3625214A
(en)
|
1970-05-18 |
1971-12-07 |
Alza Corp |
Drug-delivery device
|
|
US3713919A
(en)
|
1970-08-17 |
1973-01-30 |
Du Pont |
Chemical foaming of water-bearing explosives with n,n'-dimitrosopentamethylene-tetramine
|
|
US3995631A
(en)
|
1971-01-13 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
|
|
US4034756A
(en)
|
1971-01-13 |
1977-07-12 |
Alza Corporation |
Osmotically driven fluid dispenser
|
|
US3732865A
(en)
|
1971-01-13 |
1973-05-15 |
Alza Corp |
Osmotic dispenser
|
|
US4211771A
(en)
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
|
JPS523342B2
(enExample)
|
1972-01-26 |
1977-01-27 |
|
|
|
BE795516A
(fr)
|
1972-02-17 |
1973-08-16 |
Ciba Geigy |
Preparations de peptides huileuses et injectables et procede pour leur preparation
|
|
US3797492A
(en)
|
1972-12-27 |
1974-03-19 |
Alza Corp |
Device for dispensing product with directional guidance member
|
|
US3995632A
(en)
|
1973-05-04 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser
|
|
GB1413186A
(en)
|
1973-06-27 |
1975-11-12 |
Toyo Jozo Kk |
Process for encapsulation of medicaments
|
|
DE2528516A1
(de)
|
1974-07-05 |
1976-01-22 |
Sandoz Ag |
Neue galenische zubereitung
|
|
JPS523653A
(en)
|
1975-06-27 |
1977-01-12 |
Fuji Photo Film Co Ltd |
Process for producing fine polymer particles
|
|
US3987790A
(en)
|
1975-10-01 |
1976-10-26 |
Alza Corporation |
Osmotically driven fluid dispenser
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4078060A
(en)
|
1976-05-10 |
1978-03-07 |
Richardson-Merrell Inc. |
Method of inducing an estrogenic response
|
|
US4111201A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for delivering selected beneficial agents having varying degrees of solubility
|
|
US4203439A
(en)
|
1976-11-22 |
1980-05-20 |
Alza Corporation |
Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
|
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
|
US4111202A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
|
USD258837S
(en)
|
1977-10-17 |
1981-04-07 |
Gambro Dialysatoren Gmbh And Co. Kg |
Dialyzer cartridge
|
|
USD259458S
(en)
|
1978-06-09 |
1981-06-09 |
Fuller Charles R |
Support pad for an infant
|
|
US4243030A
(en)
|
1978-08-18 |
1981-01-06 |
Massachusetts Institute Of Technology |
Implantable programmed microinfusion apparatus
|
|
US4305927A
(en)
|
1979-02-05 |
1981-12-15 |
Alza Corporation |
Method for the management of intraocular pressure
|
|
US4373527B1
(en)
|
1979-04-27 |
1995-06-27 |
Univ Johns Hopkins |
Implantable programmable medication infusion system
|
|
US4310516A
(en)
|
1980-02-01 |
1982-01-12 |
Block Drug Company Inc. |
Cosmetic and pharmaceutical vehicle thickened with solid emulsifier
|
|
US4384975A
(en)
|
1980-06-13 |
1983-05-24 |
Sandoz, Inc. |
Process for preparation of microspheres
|
|
AU546785B2
(en)
|
1980-07-23 |
1985-09-19 |
Commonwealth Of Australia, The |
Open-loop controlled infusion of diabetics
|
|
US4350271A
(en)
|
1980-08-22 |
1982-09-21 |
Alza Corporation |
Water absorbing fluid dispenser
|
|
US4376118A
(en)
|
1980-10-06 |
1983-03-08 |
Miles Laboratories, Inc. |
Stable nonaqueous solution of tetracycline salt
|
|
US4389330A
(en)
|
1980-10-06 |
1983-06-21 |
Stolle Research And Development Corporation |
Microencapsulation process
|
|
PH19942A
(en)
|
1980-11-18 |
1986-08-14 |
Sintex Inc |
Microencapsulation of water soluble polypeptides
|
|
US4340054A
(en)
|
1980-12-29 |
1982-07-20 |
Alza Corporation |
Dispenser for delivering fluids and solids
|
|
US4444498A
(en)
|
1981-02-27 |
1984-04-24 |
Bentley Laboratories |
Apparatus and method for measuring blood oxygen saturation
|
|
US4455145A
(en)
|
1981-07-10 |
1984-06-19 |
Alza Corporation |
Dispensing device with internal drive
|
|
AU561343B2
(en)
|
1981-10-19 |
1987-05-07 |
Genentech Inc. |
Human immune interferon by recombinant dna
|
|
EP0079143A3
(en)
|
1981-10-20 |
1984-11-21 |
Adnovum Ag |
Pseudoplastic gel transfer
|
|
EP0080879B1
(en)
|
1981-11-28 |
1986-10-01 |
Sunstar Kabushiki Kaisha |
Pharmaceutical composition containing interferon in stable state
|
|
US5004689A
(en)
|
1982-02-22 |
1991-04-02 |
Biogen, Massachusetts |
DNA sequences, recombinant DNA molecules and processes for producing human gamma interferon-like polypeptides in high yields
|
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
|
US4455143A
(en)
|
1982-03-22 |
1984-06-19 |
Alza Corporation |
Osmotic device for dispensing two different medications
|
|
US6936694B1
(en)
|
1982-05-06 |
2005-08-30 |
Intermune, Inc. |
Manufacture and expression of large structural genes
|
|
DE3220116A1
(de)
|
1982-05-28 |
1983-12-01 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4530840A
(en)
|
1982-07-29 |
1985-07-23 |
The Stolle Research And Development Corporation |
Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
|
|
US4753651A
(en)
|
1982-08-30 |
1988-06-28 |
Alza Corporation |
Self-driven pump
|
|
US4966843A
(en)
|
1982-11-01 |
1990-10-30 |
Cetus Corporation |
Expression of interferon genes in Chinese hamster ovary cells
|
|
US4552561A
(en)
|
1982-12-23 |
1985-11-12 |
Alza Corporation |
Body mounted pump housing and pump assembly employing the same
|
|
US4673405A
(en)
|
1983-03-04 |
1987-06-16 |
Alza Corporation |
Osmotic system with instant drug availability
|
|
US4639244A
(en)
|
1983-05-03 |
1987-01-27 |
Nabil I. Rizk |
Implantable electrophoretic pump for ionic drugs and associated methods
|
|
US4783337A
(en)
|
1983-05-11 |
1988-11-08 |
Alza Corporation |
Osmotic system comprising plurality of members for dispensing drug
|
|
US4765989A
(en)
|
1983-05-11 |
1988-08-23 |
Alza Corporation |
Osmotic device for administering certain drugs
|
|
DE3320583A1
(de)
|
1983-06-08 |
1984-12-13 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
|
|
JPS6058915A
(ja)
|
1983-09-12 |
1985-04-05 |
Fujisawa Pharmaceut Co Ltd |
薬物含有脂質小胞体製剤
|
|
US4594108A
(en)
|
1983-09-19 |
1986-06-10 |
The Dow Chemical Company |
Highly pseudoplastic polymer solutions
|
|
US5385738A
(en)
|
1983-10-14 |
1995-01-31 |
Sumitomo Pharmaceuticals Company, Ltd. |
Sustained-release injection
|
|
US5639639A
(en)
|
1983-11-02 |
1997-06-17 |
Genzyme Corporation |
Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
|
|
US4923805A
(en)
|
1983-11-02 |
1990-05-08 |
Integrated Genetics, Inc. |
Fsh
|
|
US4840896A
(en)
|
1983-11-02 |
1989-06-20 |
Integrated Genetics, Inc. |
Heteropolymeric protein
|
|
MX9203641A
(es)
|
1983-12-16 |
1992-07-01 |
Genentech Inc |
Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
|
|
US4855238A
(en)
|
1983-12-16 |
1989-08-08 |
Genentech, Inc. |
Recombinant gamma interferons having enhanced stability and methods therefor
|
|
US4851228A
(en)
|
1984-06-20 |
1989-07-25 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic
|
|
US5231176A
(en)
|
1984-08-27 |
1993-07-27 |
Genentech, Inc. |
Distinct family DNA encoding of human leukocyte interferons
|
|
US5120832A
(en)
|
1984-08-27 |
1992-06-09 |
Genentech, Inc. |
Distinct family of human leukocyte interferons
|
|
US4927687A
(en)
|
1984-10-01 |
1990-05-22 |
Biotek, Inc. |
Sustained release transdermal drug delivery composition
|
|
US5411951A
(en)
|
1984-10-04 |
1995-05-02 |
Monsanto Company |
Prolonged release of biologically active somatotropin
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
FI90990C
(fi)
|
1984-12-18 |
1994-04-25 |
Boehringer Ingelheim Int |
Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
|
|
US4655462A
(en)
|
1985-01-07 |
1987-04-07 |
Peter J. Balsells |
Canted coiled spring and seal
|
|
JPS61189230A
(ja)
|
1985-02-19 |
1986-08-22 |
Nippon Kayaku Co Ltd |
エトポシド製剤
|
|
US4609374A
(en)
|
1985-04-22 |
1986-09-02 |
Alza Corporation |
Osmotic device comprising means for governing initial time of agent release therefrom
|
|
ATE78262T1
(de)
|
1985-06-11 |
1992-08-15 |
Ciba Geigy Ag |
Hybrid-interferone.
|
|
US4845196A
(en)
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
|
US4847079A
(en)
|
1985-07-29 |
1989-07-11 |
Schering Corporation |
Biologically stable interferon compositions comprising thimerosal
|
|
IE59361B1
(en)
|
1986-01-24 |
1994-02-09 |
Akzo Nv |
Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension
|
|
DE3607835A1
(de)
|
1986-03-10 |
1987-09-24 |
Boehringer Ingelheim Int |
Hybridinterferone, deren verwendung als arzneimittel und als zwischenprodukte zur herstellung von antikoerpern und deren verwendung sowie verfahren zu ihrer herstellung
|
|
US4865845A
(en)
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
|
US4737437A
(en)
|
1986-03-27 |
1988-04-12 |
East Shore Chemical Co. |
Light sensitive diazo compound, composition and method of making the composition
|
|
US7138486B2
(en)
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US5120712A
(en)
|
1986-05-05 |
1992-06-09 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US6849708B1
(en)
|
1986-05-05 |
2005-02-01 |
The General Hospital Corporation |
Insulinotropic hormone and uses thereof
|
|
US5118666A
(en)
|
1986-05-05 |
1992-06-02 |
The General Hospital Corporation |
Insulinotropic hormone
|
|
US4755180A
(en)
|
1986-06-16 |
1988-07-05 |
Alza Corporation |
Dosage form comprising solubility regulating member
|
|
DE3636123A1
(de)
|
1986-10-23 |
1988-05-05 |
Rentschler Arzneimittel |
Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
|
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
|
ZA878295B
(en)
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
|
JPS63145112A
(ja)
|
1986-12-09 |
1988-06-17 |
Honda Motor Co Ltd |
自動車のリヤサスペンシヨン装置
|
|
DE3642096A1
(de)
|
1986-12-10 |
1988-06-16 |
Boehringer Ingelheim Int |
Pferde-(gamma)-interferon
|
|
US5371089A
(en)
|
1987-02-26 |
1994-12-06 |
Senetek, Plc |
Method and composition for ameliorating the adverse effects of aging
|
|
US5278151A
(en)
|
1987-04-02 |
1994-01-11 |
Ocular Research Of Boston, Inc. |
Dry eye treatment solution
|
|
JPH0720866B2
(ja)
|
1987-05-15 |
1995-03-08 |
三生製薬株式会社 |
エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
|
|
US4892778A
(en)
|
1987-05-27 |
1990-01-09 |
Alza Corporation |
Juxtaposed laminated arrangement
|
|
US4940465A
(en)
|
1987-05-27 |
1990-07-10 |
Felix Theeuwes |
Dispenser comprising displaceable matrix with solid state properties
|
|
US4874388A
(en)
|
1987-06-25 |
1989-10-17 |
Alza Corporation |
Multi-layer delivery system
|
|
US5023088A
(en)
|
1987-06-25 |
1991-06-11 |
Alza Corporation |
Multi-unit delivery system
|
|
US5938654A
(en)
|
1987-06-25 |
1999-08-17 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US4915949A
(en)
|
1987-07-13 |
1990-04-10 |
Alza Corporation |
Dispenser with movable matrix comprising a plurality of tiny pills
|
|
US4897268A
(en)
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
|
DE19975054I2
(de)
|
1987-08-08 |
2000-04-13 |
Akzo Nobel Nv |
Kontrazeptives Implantat
|
|
US4915954A
(en)
|
1987-09-03 |
1990-04-10 |
Alza Corporation |
Dosage form for delivering a drug at two different rates
|
|
US5756450A
(en)
|
1987-09-15 |
1998-05-26 |
Novartis Corporation |
Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
|
|
US4886668A
(en)
|
1987-09-24 |
1989-12-12 |
Merck & Co., Inc. |
Multiparticulate controlled porosity osmotic pump
|
|
GB8723846D0
(en)
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
|
AU2810189A
(en)
|
1987-10-30 |
1989-05-23 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
|
US4917895A
(en)
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
|
US4961253A
(en)
|
1988-04-25 |
1990-10-09 |
Peter J. Balsells |
Manufacturing method for canted-coil spring with turn angle and seal
|
|
US4964204A
(en)
|
1988-04-25 |
1990-10-23 |
Peter J. Balsells |
Method for making a garter-type axially-resilient coil spring
|
|
US4826144A
(en)
|
1988-04-25 |
1989-05-02 |
Peter J. Balsells |
Inside back angle canted coil spring
|
|
US4934666A
(en)
|
1988-04-25 |
1990-06-19 |
Peter J. Balsells |
Coiled spring electromagnetic shielding gasket
|
|
US5160122A
(en)
|
1990-03-20 |
1992-11-03 |
Peter J. Balsells |
Coil spring with an elastomer having a hollow coil cross section
|
|
US5072070A
(en)
|
1989-12-01 |
1991-12-10 |
Peter J. Balsells |
Device for sealing electromagnetic waves
|
|
US4907788A
(en)
|
1988-04-25 |
1990-03-13 |
Peter J. Balsells |
Dual concentric canted-coil spring apparatus
|
|
US5203849A
(en)
|
1990-03-20 |
1993-04-20 |
Balsells Peter J |
Canted coil spring in length filled with an elastomer
|
|
US5079388A
(en)
|
1989-12-01 |
1992-01-07 |
Peter J. Balsells |
Gasket for sealing electromagnetic waves
|
|
US4915366A
(en)
|
1988-04-25 |
1990-04-10 |
Peter J. Balsells |
Outside back angle canted coil spring
|
|
US5117066A
(en)
|
1988-04-25 |
1992-05-26 |
Peter J. Balsells |
Retaining and locking electromagnetic gasket
|
|
US4876781A
(en)
|
1988-04-25 |
1989-10-31 |
Peter J. Balsells |
Method of making a garter-type axially resilient coiled spring
|
|
US4830344A
(en)
|
1988-04-25 |
1989-05-16 |
Peter J. Balsells |
Canted-coil spring with turn angle and seal
|
|
US4893795A
(en)
|
1988-08-15 |
1990-01-16 |
Peter J. Balsells |
Radially loaded canted coiled spring with turn angle
|
|
US5108078A
(en)
|
1988-04-25 |
1992-04-28 |
Peter J. Balsells |
Canted-coil spring loaded while in a cavity
|
|
ATE94955T1
(de)
|
1988-04-25 |
1993-10-15 |
Peter J Balsells |
In sich geschlossene ringfoermige schraubenfeder mit aeusserem, rueckwaertigem neigungswinkel.
|
|
US4974821A
(en)
|
1988-04-25 |
1990-12-04 |
Peter J. Balsells |
Canted-coil spring with major axis radial loading
|
|
US4931285A
(en)
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
|
US5024842A
(en)
|
1988-04-28 |
1991-06-18 |
Alza Corporation |
Annealed coats
|
|
US5160743A
(en)
|
1988-04-28 |
1992-11-03 |
Alza Corporation |
Annealed composition for pharmaceutically acceptable drug
|
|
US5006346A
(en)
|
1988-04-28 |
1991-04-09 |
Alza Corporation |
Delivery system
|
|
JP2827287B2
(ja)
|
1988-07-05 |
1998-11-25 |
武田薬品工業株式会社 |
水溶性薬物含有徐放型マイクロカプセル
|
|
JP2794022B2
(ja)
|
1988-11-11 |
1998-09-03 |
三生製薬株式会社 |
ブナゾシン或いはその塩類含有経皮適用製剤
|
|
US5126141A
(en)
|
1988-11-16 |
1992-06-30 |
Mediventures Incorporated |
Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
|
|
US5057318A
(en)
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
|
US5110596A
(en)
|
1988-12-13 |
1992-05-05 |
Alza Corporation |
Delivery system comprising means for delivering agent to livestock
|
|
US5728088A
(en)
|
1988-12-13 |
1998-03-17 |
Alza Corporation |
Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals
|
|
US5059423A
(en)
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
|
US5034229A
(en)
|
1988-12-13 |
1991-07-23 |
Alza Corporation |
Dispenser for increasing feed conversion of hog
|
|
US5234424A
(en)
|
1988-12-28 |
1993-08-10 |
Alza Corporation |
Osmotically driven syringe
|
|
US4969884A
(en)
|
1988-12-28 |
1990-11-13 |
Alza Corporation |
Osmotically driven syringe
|
|
US4976966A
(en)
|
1988-12-29 |
1990-12-11 |
Alza Corporation |
Delayed release osmotically driven fluid dispenser
|
|
IL92344A0
(en)
|
1989-01-04 |
1990-07-26 |
Gist Brocades Nv |
Microencapsulation of bioactive substances in biocompatible polymers,microcapsules obtained and pharmaceutical preparation comprising said microcapsules
|
|
US5288479A
(en)
|
1989-01-17 |
1994-02-22 |
Sterling Drug, Inc. |
Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
|
|
US5906816A
(en)
|
1995-03-16 |
1999-05-25 |
University Of Florida |
Method for treatment of autoimmune diseases
|
|
US5705363A
(en)
|
1989-03-02 |
1998-01-06 |
The Women's Research Institute |
Recombinant production of human interferon τ polypeptides and nucleic acids
|
|
US5219572A
(en)
|
1989-03-17 |
1993-06-15 |
Pitman-Moore, Inc. |
Controlled release delivery device for macromolecular proteins
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
ATE99546T1
(de)
|
1989-05-01 |
1994-01-15 |
Alkermes Inc |
Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekuelen.
|
|
WO1990013361A1
(en)
|
1989-05-04 |
1990-11-15 |
Southern Research Institute |
Improved encapsulation process and products therefrom
|
|
US5133974A
(en)
|
1989-05-05 |
1992-07-28 |
Kv Pharmaceutical Company |
Extended release pharmaceutical formulations
|
|
US5656207A
(en)
|
1989-06-24 |
1997-08-12 |
Gen Probe Incorporated |
Detecting or quantifying multiple analytes using labelling techniques
|
|
US5126142A
(en)
|
1989-07-18 |
1992-06-30 |
Alza Corporation |
Dispenser comprising ionophore
|
|
US5225205A
(en)
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
|
US5439688A
(en)
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
|
EP0489843A4
(en)
|
1989-08-28 |
1992-08-12 |
Pharmaceutical Delivery Systems, Inc. |
Bioerodible polymers useful for the controlled release of therapeutic agents
|
|
US5112614A
(en)
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
|
US5290558A
(en)
|
1989-09-21 |
1994-03-01 |
Osteotech, Inc. |
Flowable demineralized bone powder composition and its use in bone repair
|
|
SE465950B
(sv)
|
1989-10-23 |
1991-11-25 |
Medinvent Sa |
Kombination av ett aggregat partikelformat, kristallint eller frystorkat laekemedel med en pseudoplastisk gel foer beredning av ett injicerbart preparat samt foerfarande foer dess framstaellning
|
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
|
WO1991007160A1
(fr)
|
1989-11-13 |
1991-05-30 |
Medicorp Holding S.A. |
Flacon de stockage contenant un composant d'une solution medicamenteuse
|
|
JPH03236317A
(ja)
|
1989-12-06 |
1991-10-22 |
Sansei Seiyaku Kk |
ドパミン誘導体含有経皮用製剤
|
|
US5540914A
(en)
|
1989-12-15 |
1996-07-30 |
The Board Of Regents Of The University Of Oklahoma |
Pigmentation enhancer and method
|
|
US5030216A
(en)
|
1989-12-15 |
1991-07-09 |
Alza Corporation |
Osmotically driven syringe
|
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
USD326718S
(en)
|
1989-12-26 |
1992-06-02 |
Minnesota Mining And Manufacturing Co. |
Blood sensor cassette
|
|
US5223266A
(en)
|
1990-01-24 |
1993-06-29 |
Alza Corporation |
Long-term delivery device with early startup
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
US5213809A
(en)
|
1990-01-24 |
1993-05-25 |
Alza Corporation |
Delivery system comprising means for controlling internal pressure
|
|
US5126147A
(en)
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
|
US5478564A
(en)
|
1990-02-22 |
1995-12-26 |
Teva Pharmaceutical Industries, Ltd. |
Preparation of microparticles for controlled release of water-soluble substances
|
|
US5122128A
(en)
|
1990-03-15 |
1992-06-16 |
Alza Corporation |
Orifice insert for a ruminal bolus
|
|
US5120306A
(en)
|
1990-03-21 |
1992-06-09 |
Gosselin Leon F |
Direct delivery of anti-inflammatories to the proximal small bowel
|
|
US5213810A
(en)
|
1990-03-30 |
1993-05-25 |
American Cyanamid Company |
Stable compositions for parenteral administration and method of making same
|
|
US5207752A
(en)
|
1990-03-30 |
1993-05-04 |
Alza Corporation |
Iontophoretic drug delivery system with two-stage delivery profile
|
|
US5324280A
(en)
|
1990-04-02 |
1994-06-28 |
Alza Corporation |
Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
US5290271A
(en)
|
1990-05-14 |
1994-03-01 |
Jernberg Gary R |
Surgical implant and method for controlled release of chemotherapeutic agents
|
|
US5374620A
(en)
|
1990-06-07 |
1994-12-20 |
Genentech, Inc. |
Growth-promoting composition and its use
|
|
US5180591A
(en)
|
1990-07-11 |
1993-01-19 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234692A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234695A
(en)
|
1990-07-24 |
1993-08-10 |
Eastman Kodak Company |
Water dispersible vitamin E composition
|
|
USD329278S
(en)
|
1990-10-01 |
1992-09-08 |
Gallup Allen I |
Infant's bathing support
|
|
US5300302A
(en)
|
1990-10-04 |
1994-04-05 |
Nestec S.A. |
Pharmaceutical composition in gel form in a dispensing package
|
|
US5529914A
(en)
|
1990-10-15 |
1996-06-25 |
The Board Of Regents The Univeristy Of Texas System |
Gels for encapsulation of biological materials
|
|
US5151093A
(en)
|
1990-10-29 |
1992-09-29 |
Alza Corporation |
Osmotically driven syringe with programmable agent delivery
|
|
US5122377A
(en)
|
1990-11-19 |
1992-06-16 |
A.H. Robins, Company, Incorporated |
Oral delivery system for veterinary drugs
|
|
IT1243390B
(it)
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
|
US5161806A
(en)
|
1990-12-17 |
1992-11-10 |
Peter J. Balsells |
Spring-loaded, hollow, elliptical ring seal
|
|
GB9027422D0
(en)
|
1990-12-18 |
1991-02-06 |
Scras |
Osmotically driven infusion device
|
|
PT99989A
(pt)
|
1991-01-09 |
1994-05-31 |
Alza Corp |
Dispositivos biodegradaveis e composicoes para libertacao difusivel de agentes
|
|
NL9100160A
(nl)
|
1991-01-30 |
1992-08-17 |
Texas Instruments Holland |
Injector.
|
|
US5443459A
(en)
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US5861166A
(en)
|
1991-03-12 |
1999-01-19 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
HUT69390A
(en)
|
1991-05-07 |
1995-09-28 |
Dynagen Inc |
Controlled, sustained release delivery system for smoking cessation
|
|
US5113938A
(en)
|
1991-05-07 |
1992-05-19 |
Clayton Charley H |
Whipstock
|
|
US5137727A
(en)
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
EP0520119A1
(de)
|
1991-06-17 |
1992-12-30 |
Spirig Ag Pharmazeutische Präparate |
Neue orale Diclofenaczubereitung
|
|
US5252338A
(en)
|
1991-06-27 |
1993-10-12 |
Alza Corporation |
Therapy delayed
|
|
US5190765A
(en)
|
1991-06-27 |
1993-03-02 |
Alza Corporation |
Therapy delayed
|
|
HU222501B1
(hu)
|
1991-06-28 |
2003-07-28 |
Endorecherche Inc. |
MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
|
|
DE4122217C2
(de)
|
1991-07-04 |
1997-02-13 |
Merz & Co Gmbh & Co |
Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
|
|
US5288214A
(en)
|
1991-09-30 |
1994-02-22 |
Toshio Fukuda |
Micropump
|
|
YU87892A
(sh)
|
1991-10-01 |
1995-12-04 |
Eli Lilly And Company Lilly Corporate Center |
Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
|
|
EP0664118B1
(en)
|
1991-10-04 |
1999-08-25 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release tablet
|
|
PT100944B
(pt)
|
1991-10-10 |
2000-02-29 |
Alza Corp |
Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
|
|
US5288502A
(en)
|
1991-10-16 |
1994-02-22 |
The University Of Texas System |
Preparation and uses of multi-phase microspheres
|
|
US5318780A
(en)
|
1991-10-30 |
1994-06-07 |
Mediventures Inc. |
Medical uses of in situ formed gels
|
|
US5236707A
(en)
|
1991-11-08 |
1993-08-17 |
Dallas Biotherapeutics, Inc. |
Stabilization of human interferon
|
|
AU3136293A
(en)
|
1991-11-15 |
1993-06-15 |
Isp Investments Inc. |
Pharmaceutical tablet with pvp having an enhanced drug dissolution rate
|
|
DE4137649C2
(de)
|
1991-11-15 |
1997-11-20 |
Gerhard Dingler |
Bauelement
|
|
US5213310A
(en)
|
1991-12-04 |
1993-05-25 |
Trli, Inc. |
Hydraulic release valve
|
|
US5200195A
(en)
|
1991-12-06 |
1993-04-06 |
Alza Corporation |
Process for improving dosage form delivery kinetics
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5223265A
(en)
|
1992-01-10 |
1993-06-29 |
Alza Corporation |
Osmotic device with delayed activation of drug delivery
|
|
US5658593A
(en)
|
1992-01-16 |
1997-08-19 |
Coletica |
Injectable compositions containing collagen microcapsules
|
|
US5676942A
(en)
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
|
US5456679A
(en)
|
1992-02-18 |
1995-10-10 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5308348A
(en)
|
1992-02-18 |
1994-05-03 |
Alza Corporation |
Delivery devices with pulsatile effect
|
|
US5209746A
(en)
|
1992-02-18 |
1993-05-11 |
Alza Corporation |
Osmotically driven delivery devices with pulsatile effect
|
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
|
EP0632820B1
(en)
|
1992-02-28 |
2000-05-17 |
Collagen Corporation |
High concentration homogenized collagen compositions
|
|
US5221278A
(en)
|
1992-03-12 |
1993-06-22 |
Alza Corporation |
Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
|
|
US5656297A
(en)
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
|
ZA932272B
(en)
|
1992-03-30 |
1993-10-19 |
Alza Corp |
Viscous suspensions of controlled-release drug particles
|
|
MX9301821A
(es)
|
1992-03-30 |
1994-03-31 |
Alza Corp |
Sistema de matriz polimerica biodegradable regulador de degradacion y metodo de tratamiento del mismo.
|
|
US6197346B1
(en)
|
1992-04-24 |
2001-03-06 |
Brown Universtiy Research Foundation |
Bioadhesive microspheres and their use as drug delivery and imaging systems
|
|
FR2690622B1
(fr)
|
1992-04-29 |
1995-01-20 |
Chronotec |
Système de pompe à perfusion ambulatoire programmable.
|
|
US5314685A
(en)
|
1992-05-11 |
1994-05-24 |
Agouron Pharmaceuticals, Inc. |
Anhydrous formulations for administering lipophilic agents
|
|
US5711968A
(en)
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
|
JP2651320B2
(ja)
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
|
US5413672A
(en)
|
1992-07-22 |
1995-05-09 |
Ngk Insulators, Ltd. |
Method of etching sendust and method of pattern-etching sendust and chromium films
|
|
US5512293A
(en)
|
1992-07-23 |
1996-04-30 |
Alza Corporation |
Oral sustained release drug delivery device
|
|
US5609885A
(en)
|
1992-09-15 |
1997-03-11 |
Alza Corporation |
Osmotic membrane and delivery device
|
|
GB9223146D0
(en)
|
1992-11-05 |
1992-12-16 |
Scherer Corp R P |
Vented capsule
|
|
EP0596161B1
(en)
|
1992-11-06 |
1998-02-04 |
Texas Instruments Incorporated |
Apparatus for subcutaneous introduction of a needle
|
|
EP0669128B1
(en)
|
1992-11-17 |
2000-01-05 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Sustained-release microsphere containing antipsychotic and process for producing the same
|
|
USD342855S
(en)
|
1992-11-20 |
1994-01-04 |
Butler Ii George D |
Combined infant cushion and cover
|
|
US5260069A
(en)
|
1992-11-27 |
1993-11-09 |
Anda Sr Pharmaceuticals Inc. |
Pulsatile particles drug delivery system
|
|
SE9203594D0
(sv)
|
1992-11-30 |
1992-11-30 |
Christer Nystroem |
Laekemedel i dispersa system
|
|
JPH08503950A
(ja)
|
1992-12-02 |
1996-04-30 |
アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド |
徐放性成長ホルモン含有マイクロスフェア
|
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
|
DK0686045T3
(da)
|
1993-02-23 |
2001-03-05 |
Genentech Inc |
Stabilisering af med organisk opløsningsmiddel behandlede polypeptider med et hjælpestof
|
|
US5368588A
(en)
|
1993-02-26 |
1994-11-29 |
Bettinger; David S. |
Parenteral fluid medication reservoir pump
|
|
US5981719A
(en)
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
AU6410494A
(en)
|
1993-03-17 |
1994-10-11 |
Alza Corporation |
Device for the transdermal administration of alprazolam
|
|
US5514110A
(en)
|
1993-03-22 |
1996-05-07 |
Teh; Eutiquio L. |
Automatic flow control device
|
|
NZ250844A
(en)
|
1993-04-07 |
1996-03-26 |
Pfizer |
Treatment of non-insulin dependant diabetes with peptides; composition
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
TW404844B
(en)
|
1993-04-08 |
2000-09-11 |
Oxford Biosciences Ltd |
Needleless syringe
|
|
NZ247516A
(en)
|
1993-04-28 |
1995-02-24 |
Bernard Charles Sherman |
Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
|
|
US5424286A
(en)
|
1993-05-24 |
1995-06-13 |
Eng; John |
Exendin-3 and exendin-4 polypeptides, and pharmaceutical compositions comprising same
|
|
US5639477A
(en)
|
1993-06-23 |
1997-06-17 |
Alza Corporation |
Ruminal drug delivery device
|
|
AU7396294A
(en)
|
1993-06-25 |
1995-01-24 |
Alza Corporation |
Incorporating poly-n-vinyl amide in a transdermal system
|
|
WO1995001161A1
(en)
|
1993-06-29 |
1995-01-12 |
Leiras Oy |
Pack for use in, and method of hormonal replacement therapy
|
|
EP1288224B1
(en)
|
1993-08-09 |
2008-06-25 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Therapeutic peptide derivatives
|
|
US5498255A
(en)
|
1993-08-17 |
1996-03-12 |
Alza Corporation |
Osmotic device for protracted pulsatile delivery of agent
|
|
US5385887A
(en)
|
1993-09-10 |
1995-01-31 |
Genetics Institute, Inc. |
Formulations for delivery of osteogenic proteins
|
|
JP2700141B2
(ja)
|
1993-09-17 |
1998-01-19 |
富士化学工業株式会社 |
リン酸水素カルシウム及びその製法並びにそれを用いた賦形剤
|
|
NZ274711A
(en)
|
1993-09-29 |
1996-11-26 |
Alza Corp |
Composition for administration of active agent by application to a body surface or membrane comprising permeability enhancing amount of monoglyceride(s) and lactate ester(s)
|
|
US6913767B1
(en)
|
1993-10-25 |
2005-07-05 |
Genentech, Inc. |
Compositions for microencapsulation of antigens for use as vaccines
|
|
ATE212830T1
(de)
|
1993-11-19 |
2002-02-15 |
Alkermes Inc |
Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel
|
|
ATE288270T1
(de)
|
1993-11-19 |
2005-02-15 |
Janssen Pharmaceutica Nv |
Mikroverkapselte 1,2-benzazole
|
|
US5650173A
(en)
|
1993-11-19 |
1997-07-22 |
Alkermes Controlled Therapeutics Inc. Ii |
Preparation of biodegradable microparticles containing a biologically active agent
|
|
JPH07196479A
(ja)
|
1994-01-04 |
1995-08-01 |
Unitika Ltd |
マイクロカプセルの製造法
|
|
USD358644S
(en)
|
1994-01-18 |
1995-05-23 |
Bio Medic Data Systems, Inc. |
Transponder implanter
|
|
FR2715306B1
(fr)
|
1994-01-25 |
1996-03-15 |
Oreal |
Composition cosmétique ou dermopharmaceutique sous forme de pâte souple et procédé de préparation de ladite composition.
|
|
US6241734B1
(en)
|
1998-08-14 |
2001-06-05 |
Kyphon, Inc. |
Systems and methods for placing materials into bone
|
|
US5540665A
(en)
|
1994-01-31 |
1996-07-30 |
Alza Corporation |
Gas driven dispensing device and gas generating engine therefor
|
|
AU691249B2
(en)
|
1994-02-04 |
1998-05-14 |
Lipocore Holding Ab |
Bilayer preparations
|
|
US5697975A
(en)
|
1994-02-09 |
1997-12-16 |
The University Of Iowa Research Foundation |
Human cerebral cortex neural prosthetic for tinnitus
|
|
US5458888A
(en)
|
1994-03-02 |
1995-10-17 |
Andrx Pharmaceuticals, Inc. |
Controlled release tablet formulation
|
|
PT741577E
(pt)
|
1994-03-07 |
2003-03-31 |
Imperial College |
Utilizacao do subtipo de interferao alfa 8 na preparacao de medicamentos para tratar infeccoes virais do figado
|
|
ZA953078B
(en)
|
1994-04-28 |
1996-01-05 |
Alza Corp |
Effective therapy for epilepsies
|
|
EP0768867B1
(en)
|
1994-06-13 |
2002-10-09 |
Alza Corporation |
Dosage form for administering drug in liquid formulation
|
|
NL9401150A
(nl)
|
1994-07-12 |
1996-02-01 |
Nederland Ptt |
Werkwijze voor het aan een ontvangzijde aanbieden van een van een zendzijde afkomstig eerste aantal videosignalen, alsmede systeem, alsmede zender, alsmede netwerk, en alsmede ontvanger.
|
|
WO1996002232A1
(en)
|
1994-07-13 |
1996-02-01 |
Alza Corporation |
Composition and method for enhancing transdermal electrotransport agent delivery
|
|
US5633011A
(en)
|
1994-08-04 |
1997-05-27 |
Alza Corporation |
Progesterone replacement therapy
|
|
US5574008A
(en)
|
1994-08-30 |
1996-11-12 |
Eli Lilly And Company |
Biologically active fragments of glucagon-like insulinotropic peptide
|
|
US5512549A
(en)
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
US5595759A
(en)
|
1994-11-10 |
1997-01-21 |
Alza Corporation |
Process for providing therapeutic composition
|
|
DE69529572T2
(de)
|
1994-11-10 |
2003-06-18 |
The University Of Kentucky Research Foundation, Lexington |
Implantierbare wiederauffüllbare vorrichtung mit gesteuerter freisetzung zur verabreichung von arzneistoffen unmittelbar an einen inneren teil des körpers
|
|
US5574010A
(en)
|
1994-11-14 |
1996-11-12 |
The Regents Of The University Of California |
Treatment of pancreatic tumors with peptide YY and analogs thereof
|
|
FR2730246B1
(fr)
|
1995-02-03 |
1997-03-21 |
Icbt Perfojet Sa |
Procede pour la fabrication d'une nappe textile non tissee par jets d'eau sous pression, et installation pour la mise en oeuvre de ce procede
|
|
FR2731150B1
(fr)
|
1995-03-03 |
1997-04-18 |
Oreal |
Utilisation de composes amphiphiles en tant qu'agent epaississant de milieux non aqueux
|
|
US5607687A
(en)
|
1995-03-06 |
1997-03-04 |
Ethicon, Inc. |
Polymer blends containing absorbable polyoxaesters
|
|
US5595751A
(en)
|
1995-03-06 |
1997-01-21 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/or amido groups
|
|
US5700583A
(en)
|
1995-03-06 |
1997-12-23 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters containing amines or amido groups
|
|
US5618552A
(en)
|
1995-03-06 |
1997-04-08 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
|
US5597579A
(en)
|
1995-03-06 |
1997-01-28 |
Ethicon, Inc. |
Blends of absorbable polyoxaamides
|
|
US5464929A
(en)
|
1995-03-06 |
1995-11-07 |
Ethicon, Inc. |
Absorbable polyoxaesters
|
|
US6147168A
(en)
|
1995-03-06 |
2000-11-14 |
Ethicon, Inc. |
Copolymers of absorbable polyoxaesters
|
|
US6403655B1
(en)
|
1995-03-06 |
2002-06-11 |
Ethicon, Inc. |
Method of preventing adhesions with absorbable polyoxaesters
|
|
US5648088A
(en)
|
1995-03-06 |
1997-07-15 |
Ethicon, Inc. |
Blends of absorbable polyoxaesters containing amines and/or amide groups
|
|
US5698213A
(en)
|
1995-03-06 |
1997-12-16 |
Ethicon, Inc. |
Hydrogels of absorbable polyoxaesters
|
|
US5844017A
(en)
|
1995-03-06 |
1998-12-01 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters containing amines and/or amido groups
|
|
US5859150A
(en)
|
1995-03-06 |
1999-01-12 |
Ethicon, Inc. |
Prepolymers of absorbable polyoxaesters
|
|
US5962023A
(en)
|
1995-03-06 |
1999-10-05 |
Ethicon, Inc. |
Hydrogels containing absorbable polyoxaamides
|
|
US6100346A
(en)
|
1995-03-06 |
2000-08-08 |
Ethicon, Inc. |
Copolymers of polyoxaamides
|
|
IL113100A0
(en)
|
1995-03-23 |
1995-06-29 |
Schatz Anat |
Infant's mattress
|
|
US5542682A
(en)
|
1995-03-27 |
1996-08-06 |
American Variseal |
Slant coil spring and seal
|
|
US5736159A
(en)
|
1995-04-28 |
1998-04-07 |
Andrx Pharmaceuticals, Inc. |
Controlled release formulation for water insoluble drugs in which a passageway is formed in situ
|
|
CA2219991C
(en)
|
1995-05-02 |
2007-10-30 |
Taisho Pharmaceutical Co., Ltd. |
Taste masking pharmaceutical composition for oral administration
|
|
US5939286A
(en)
|
1995-05-10 |
1999-08-17 |
University Of Florida |
Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them
|
|
US5922253A
(en)
|
1995-05-18 |
1999-07-13 |
Alkermes Controlled Therapeutics, Inc. |
Production scale method of forming microparticles
|
|
US5882676A
(en)
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
|
US5718922A
(en)
|
1995-05-31 |
1998-02-17 |
Schepens Eye Research Institute, Inc. |
Intravitreal microsphere drug delivery and method of preparation
|
|
ES2182996T3
(es)
|
1995-06-06 |
2003-03-16 |
Hoffmann La Roche |
Composiciones farmaceuticas que comprenden un inhibidor de proteinasa y un monglicerido.
|
|
US6129761A
(en)
|
1995-06-07 |
2000-10-10 |
Reprogenesis, Inc. |
Injectable hydrogel compositions
|
|
PL181582B1
(pl)
|
1995-06-07 |
2001-08-31 |
Ortho Mcneil Pharm Inc |
Plaster na skóre do zapobiegania owulacji u kobiety oraz plaster na skóre do przeprowadzania hormonalnej terapii substytucyjnej PL PL PL PL PL PL PL PL
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5589187A
(en)
|
1995-06-07 |
1996-12-31 |
Wisconsin Alumni Research Foundation |
Protective encapsulation of micronutrients for ingestion by avian species
|
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
|
US6572879B1
(en)
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
|
US5690952A
(en)
|
1995-06-07 |
1997-11-25 |
Judy A. Magruder et al. |
Implantable system for delivery of fluid-sensitive agents to animals
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5782396A
(en)
|
1995-08-28 |
1998-07-21 |
United States Surgical Corporation |
Surgical stapler
|
|
US5906830A
(en)
|
1995-09-08 |
1999-05-25 |
Cygnus, Inc. |
Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
|
|
US5655593A
(en)
|
1995-09-18 |
1997-08-12 |
Kaiser Aluminum & Chemical Corp. |
Method of manufacturing aluminum alloy sheet
|
|
US5942253A
(en)
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
GB9521125D0
(en)
|
1995-10-16 |
1995-12-20 |
Unilever Plc |
Cosmetic composition
|
|
SE505146C2
(sv)
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
|
US5766620A
(en)
|
1995-10-23 |
1998-06-16 |
Theratech, Inc. |
Buccal delivery of glucagon-like insulinotropic peptides
|
|
GB9521805D0
(en)
|
1995-10-25 |
1996-01-03 |
Cortecs Ltd |
Solubilisation methods
|
|
DK0771817T3
(da)
|
1995-10-30 |
2003-07-28 |
Oleoyl Estrone Developments S |
Oleatmonoestere af østrogener til behandling af obesitet og/eller overvægt
|
|
US5908621A
(en)
|
1995-11-02 |
1999-06-01 |
Schering Corporation |
Polyethylene glycol modified interferon therapy
|
|
ES2214551T3
(es)
|
1995-11-02 |
2004-09-16 |
Schering Corporation |
Terapia de infusion continua de citocinas a baja dosis.
|
|
CA2192782C
(en)
|
1995-12-15 |
2008-10-14 |
Nobuyuki Takechi |
Production of microspheres
|
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
|
AUPN723395A0
(en)
|
1995-12-19 |
1996-01-18 |
Macnaught Medical Pty Limited |
Lubrication methods
|
|
US5980945A
(en)
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
|
DE69625623T2
(de)
|
1996-01-31 |
2003-11-06 |
Sumitomo Bakelite Co. Ltd., Tokio/Tokyo |
Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
|
|
DE69720190T2
(de)
|
1996-02-02 |
2003-12-11 |
Alza Corp |
Implantierbares system mit verzögerter freisetzung von leuprolid
|
|
US6132420A
(en)
|
1996-02-02 |
2000-10-17 |
Alza Corporation |
Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
|
|
US6395292B2
(en)
|
1996-02-02 |
2002-05-28 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6156331A
(en)
|
1996-02-02 |
2000-12-05 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
US6261584B1
(en)
|
1996-02-02 |
2001-07-17 |
Alza Corporation |
Sustained delivery of an active agent using an implantable system
|
|
WO1997028181A2
(en)
|
1996-02-02 |
1997-08-07 |
Rhomed Incorporated |
Post-labeling stabilization of radiolabeled proteins and peptides
|
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
|
US6245349B1
(en)
|
1996-02-23 |
2001-06-12 |
éLAN CORPORATION PLC |
Drug delivery compositions suitable for intravenous injection
|
|
EP1975177B1
(en)
|
1996-03-01 |
2011-04-13 |
Novo Nordisk A/S |
An appetite-suppressing peptide, its compositions and use
|
|
JPH09241153A
(ja)
|
1996-03-04 |
1997-09-16 |
Q P Corp |
静脈注射用脂肪乳剤
|
|
EP0888350A1
(en)
|
1996-03-08 |
1999-01-07 |
Zeneca Limited |
Azolobenzazepine derivatives as neurologically active agents
|
|
EP0904373A1
(en)
|
1996-03-14 |
1999-03-31 |
The Immune Response Corporation |
Targeted delivery of genes encoding interferon
|
|
US5703200A
(en)
|
1996-03-15 |
1997-12-30 |
Ethicon, Inc. |
Absorbable copolymers and blends of 6,6-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
|
|
US6190702B1
(en)
|
1996-03-28 |
2001-02-20 |
Takeda Chemical Industries, Ltd. |
Sustained-released material prepared by dispersing a lyophilized polypeptide in an oil phase
|
|
US5660858A
(en)
|
1996-04-03 |
1997-08-26 |
Research Triangle Pharmaceuticals |
Cyclosporin emulsions
|
|
US6204022B1
(en)
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
|
US6074673A
(en)
|
1996-04-22 |
2000-06-13 |
Guillen; Manuel |
Slow-release, self-absorbing, drug delivery system
|
|
US5976109A
(en)
|
1996-04-30 |
1999-11-02 |
Medtronic, Inc. |
Apparatus for drug infusion implanted within a living body
|
|
US5792477A
(en)
|
1996-05-07 |
1998-08-11 |
Alkermes Controlled Therapeutics, Inc. Ii |
Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
|
|
TW487572B
(en)
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
|
AU723694B2
(en)
|
1996-06-05 |
2000-08-31 |
Roche Diagnostics Gmbh |
Exendin analogues, processes for their preparation and medicaments containing them
|
|
EP0928136B1
(en)
|
1996-06-05 |
2003-10-22 |
Ashmont Holdings Limited |
Injectable compositions
|
|
DE29610419U1
(de)
|
1996-06-14 |
1996-10-24 |
Filtertek, S.A., Plailly |
Schwerkraftinfusionsvorrichtung für medizinische Infusionen
|
|
GB9613858D0
(en)
|
1996-07-02 |
1996-09-04 |
Cortecs Ltd |
Hydrophobic preparations
|
|
BR9710130A
(pt)
|
1996-07-03 |
1999-08-10 |
Alza Corp |
Formulações de peptídeos próticas não-aquosas
|
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
|
US5916582A
(en)
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
|
ES2227707T3
(es)
|
1996-07-15 |
2005-04-01 |
Alza Corporation |
Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina.
|
|
AR008789A1
(es)
|
1996-07-31 |
2000-02-23 |
Bayer Corp |
Piridinas y bifenilos substituidos
|
|
DE69740096D1
(de)
|
1996-08-08 |
2011-02-17 |
Amylin Pharmaceuticals Inc |
Pharmazeutische Zusammensetzung mit einem Exendin-4-Peptid
|
|
WO1998007412A1
(en)
|
1996-08-21 |
1998-02-26 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release microparticles with a hydrophobic material
|
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US5984890A
(en)
|
1996-09-27 |
1999-11-16 |
American Home Products Corporation |
Medical device for the placement of solid materials
|
|
IN184589B
(enExample)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
ES2191834T3
(es)
|
1996-10-24 |
2003-09-16 |
Alza Corp |
Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
|
|
US5817129A
(en)
|
1996-10-31 |
1998-10-06 |
Ethicon, Inc. |
Process and apparatus for coating surgical sutures
|
|
UA65549C2
(uk)
|
1996-11-05 |
2004-04-15 |
Елі Ліллі Енд Компані |
Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
|
|
DE19646392A1
(de)
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
|
US5928666A
(en)
|
1996-11-12 |
1999-07-27 |
Cygnus Inc. |
Crystalline form of estradiol and pharmaceutical formulations comprising same
|
|
DK1066081T3
(da)
|
1996-11-15 |
2003-12-01 |
Alza Corp |
Osmotisk leveringssystem og fremgangsmåde til at forbedre osmotiske leveringssystemers igangsættelse og gennemførelse
|
|
ATE318580T1
(de)
|
1996-12-20 |
2006-03-15 |
Alza Corp |
Gelzusammensetzungen und verfahren
|
|
GB9626513D0
(en)
|
1996-12-20 |
1997-02-05 |
Bioglan Ireland R & D Ltd |
A pharmaceutical composition
|
|
JP4798814B2
(ja)
|
1997-01-07 |
2011-10-19 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
食物摂取低減用のエキセンジンおよびそのアゴニストの使用
|
|
JP2001511128A
(ja)
|
1997-01-28 |
2001-08-07 |
ファルマシア・アンド・アップジョン・カンパニー |
水不溶性ポルフィリンの脂質錯体の凍結乾燥物
|
|
US5945126A
(en)
|
1997-02-13 |
1999-08-31 |
Oakwood Laboratories L.L.C. |
Continuous microsphere process
|
|
ZA981610B
(en)
|
1997-03-24 |
1999-08-26 |
Alza Corp |
Self adjustable exit port.
|
|
US5874388A
(en)
|
1997-04-02 |
1999-02-23 |
Dow Corning Corporation |
Lubricant composition for disc brake caliper pin and a disc brake asembly containing the lubricant
|
|
US6127520A
(en)
|
1997-04-15 |
2000-10-03 |
Regents Of The University Of Michigan |
Compositions and methods for the inhibition of neurotransmitter uptake of synaptic vesicles
|
|
AU6919598A
(en)
|
1997-04-17 |
1998-11-13 |
Dumex-Alpharma A/S |
A novel bioadhesive drug delivery system based on liquid crystals
|
|
AR012448A1
(es)
|
1997-04-18 |
2000-10-18 |
Ipsen Pharma Biotech |
Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada
|
|
AU753781B2
(en)
|
1997-04-28 |
2002-10-31 |
Aventis Pharma S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
|
US20020039594A1
(en)
|
1997-05-13 |
2002-04-04 |
Evan C. Unger |
Solid porous matrices and methods of making and using the same
|
|
US6113947A
(en)
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
|
SI9700186B
(sl)
|
1997-07-14 |
2006-10-31 |
Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. |
Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
|
|
MY125849A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
|
|
MY125870A
(en)
|
1997-07-25 |
2006-08-30 |
Alza Corp |
Osmotic delivery system flow modulator apparatus and method
|
|
US7157555B1
(en)
|
1997-08-08 |
2007-01-02 |
Amylin Pharmaceuticals, Inc. |
Exendin agonist compounds
|
|
GB9718986D0
(en)
|
1997-09-09 |
1997-11-12 |
Danbiosyst Uk |
Controlled release microsphere delivery system
|
|
US6023802A
(en)
|
1997-09-10 |
2000-02-15 |
King; Susan Melton |
Infant sleeper
|
|
US6172046B1
(en)
|
1997-09-21 |
2001-01-09 |
Schering Corporation |
Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
JPH11100353A
(ja)
|
1997-09-29 |
1999-04-13 |
Esupo Kk |
精製・脱臭液状エステルワックスとその組成物
|
|
ATE248583T1
(de)
|
1997-09-29 |
2003-09-15 |
Nektar Therapeutics |
In dosierinhalatoren verwendbare, stabilisierte zubereitungen
|
|
US6133429A
(en)
|
1997-10-03 |
2000-10-17 |
Becton Dickinson And Company |
Chromophores useful for the preparation of novel tandem conjugates
|
|
USD399821S
(en)
|
1997-11-07 |
1998-10-20 |
Motorola, Inc. |
Front section of a battery charger
|
|
CA2309356C
(en)
|
1997-11-14 |
2010-09-21 |
Amylin Pharmaceuticals, Inc. |
Novel exendin agonist compounds
|
|
CA2311681A1
(en)
|
1997-12-08 |
1999-06-17 |
Genentech, Inc. |
Human interferon-epsilon: a type i interferon
|
|
US6368612B1
(en)
|
1997-12-12 |
2002-04-09 |
Biohybrid Technologies Llc |
Devices for cloaking transplanted cells
|
|
CA2315890C
(en)
|
1997-12-22 |
2009-08-11 |
Alza Corporation |
Rate controlling membranes for controlled drug delivery devices
|
|
EP1300129B1
(en)
|
1997-12-29 |
2005-02-16 |
Alza Corporation |
Implant vial
|
|
PT1300174E
(pt)
|
1997-12-29 |
2005-07-29 |
Alza Corp |
''kit'' de introducao de implante
|
|
EP1041968B1
(en)
|
1997-12-29 |
2004-03-03 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
|
ATE342051T1
(de)
|
1997-12-30 |
2006-11-15 |
Alza Corp |
Verabreichungssystem für wirkstoffe mit einem membranstöpsel
|
|
US20040024068A1
(en)
|
1998-01-23 |
2004-02-05 |
Trustees Of Tufts College |
Antimicrobial compounds
|
|
IT1298575B1
(it)
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di nanoparticelle comprendenti sostanze lipidiche e sostanze antifiliche e relativo processo di
|
|
US6017545A
(en)
|
1998-02-10 |
2000-01-25 |
Modi; Pankaj |
Mixed micellar delivery system and method of preparation
|
|
US6703359B1
(en)
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
WO1999040788A1
(en)
|
1998-02-13 |
1999-08-19 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and glp-1
|
|
USD408917S
(en)
|
1998-02-26 |
1999-04-27 |
Minnesota Mining And Manufacturing Company |
Membrane support structure of a flow through cell for blood gas measurement
|
|
US6224577B1
(en)
|
1998-03-02 |
2001-05-01 |
Medrad, Inc. |
Syringes and plungers for use therein
|
|
US6056718A
(en)
|
1998-03-04 |
2000-05-02 |
Minimed Inc. |
Medication infusion set
|
|
US6245357B1
(en)
|
1998-03-06 |
2001-06-12 |
Alza Corporation |
Extended release dosage form
|
|
US6183461B1
(en)
|
1998-03-11 |
2001-02-06 |
Situs Corporation |
Method for delivering a medication
|
|
WO1999046332A1
(en)
|
1998-03-12 |
1999-09-16 |
Daicel Chemical Industries, Ltd. |
Lactone-containing resin composition, molded object thereof, and film
|
|
US6029361A
(en)
|
1998-03-25 |
2000-02-29 |
Ultratech Stepper, Inc. |
Air-guage nozzle probe structure for microlithographic image focusing
|
|
US6074660A
(en)
|
1998-04-20 |
2000-06-13 |
Ethicon, Inc. |
Absorbable polyoxaesters containing amines and/ or amido groups
|
|
TW586944B
(en)
|
1998-05-29 |
2004-05-11 |
Sumitomo Pharma |
Controlled release agent having a multi-layer structure
|
|
US8626302B2
(en)
|
1998-06-03 |
2014-01-07 |
Spr Therapeutics, Llc |
Systems and methods to place one or more leads in muscle for providing electrical stimulation to treat pain
|
|
JP2002517469A
(ja)
|
1998-06-12 |
2002-06-18 |
バイオネブラスカ，インコーポレイテッド |
グルカゴン様ペプチド−１は、耐糖能異常を有する対象におけるグルコースに対するβ細胞応答を改善する
|
|
WO2000003660A1
(en)
|
1998-07-17 |
2000-01-27 |
Skyepharma, Inc. |
Biodegradable compositions for the controlled release of encapsulated substances
|
|
US6472512B1
(en)
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
|
US7390637B2
(en)
|
1998-07-21 |
2008-06-24 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
|
US6270700B1
(en)
|
1998-07-23 |
2001-08-07 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Encapsulation of water soluble peptides
|
|
USD415073S
(en)
|
1998-08-17 |
1999-10-12 |
ScooterBug, Inc. |
Stroller
|
|
US6720407B1
(en)
|
1998-08-28 |
2004-04-13 |
Eli Lilly And Company |
Method for administering insulinotropic peptides
|
|
US6551613B1
(en)
|
1998-09-08 |
2003-04-22 |
Alza Corporation |
Dosage form comprising therapeutic formulation
|
|
US6174547B1
(en)
|
1999-07-14 |
2001-01-16 |
Alza Corporation |
Dosage form comprising liquid formulation
|
|
CN1227003C
(zh)
|
1998-09-09 |
2005-11-16 |
阿尔萨公司 |
包括液体制剂的剂型
|
|
US6248112B1
(en)
|
1998-09-30 |
2001-06-19 |
C. R. Bard, Inc. |
Implant delivery system
|
|
US6284725B1
(en)
|
1998-10-08 |
2001-09-04 |
Bionebraska, Inc. |
Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue
|
|
AU1238500A
(en)
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
|
AU1623300A
(en)
|
1998-11-13 |
2000-06-05 |
Sensor Technologies, Inc. |
Monodisperse preparations useful with implanted devices
|
|
US20030060425A1
(en)
|
1998-11-24 |
2003-03-27 |
Ahlem Clarence N. |
Immune modulation method using steroid compounds
|
|
EP1137667B1
(en)
|
1998-12-07 |
2004-11-17 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Analogues of glp-1
|
|
DE69915346T2
(de)
|
1998-12-17 |
2004-07-22 |
Alza Corp., Mountain View |
Umwandlung von flüssigkeitsgefüllten gelatinkapseln in systeme mit gesteuerter wirkstoffabgabe durch mehrfache beschichtungen
|
|
JP2002533378A
(ja)
|
1998-12-23 |
2002-10-08 |
アムジエン・インコーポレーテツド |
タンパク質の徐放用ポリオール／油懸濁液
|
|
US6433144B1
(en)
|
1999-01-12 |
2002-08-13 |
Viragen, Inc. |
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocytes and methods
|
|
DE69906132T2
(de)
|
1998-12-31 |
2003-12-18 |
Alza Corp., Mountain View |
Osmotisches verabreichungsystem mit raumsparenden kolben
|
|
WO2000039280A2
(en)
|
1998-12-31 |
2000-07-06 |
Viragen, Inc. |
Leukocyte-derived interferon preparations
|
|
WO2000040273A2
(en)
|
1999-01-08 |
2000-07-13 |
Vical Incorporated |
Treatment of viral diseases using an interferon omega expressing polynucleotide
|
|
US6703225B1
(en)
|
1999-01-12 |
2004-03-09 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α
|
|
JP2002538084A
(ja)
|
1999-01-14 |
2002-11-12 |
アミリン・ファーマシューティカルズ，インコーポレイテッド |
グルカゴンを抑制する方法
|
|
RU2242244C2
(ru)
|
1999-01-14 |
2004-12-20 |
Амилин Фармасьютикалз, Инк. |
Новые композиции агонистов эксендина и способы их введения
|
|
US7399489B2
(en)
|
1999-01-14 |
2008-07-15 |
Amylin Pharmaceuticals, Inc. |
Exendin analog formulations
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
EP1152749B1
(en)
|
1999-02-08 |
2006-04-12 |
ALZA Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
US7919109B2
(en)
|
1999-02-08 |
2011-04-05 |
Intarcia Therapeutics, Inc. |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
|
|
US6451974B1
(en)
|
1999-03-17 |
2002-09-17 |
Novo Nordisk A/S |
Method of acylating peptides and novel acylating agents
|
|
US6835194B2
(en)
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
|
US6541021B1
(en)
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
|
DK1165050T3
(da)
|
1999-04-05 |
2006-05-01 |
Mannkind Corp |
Fremgangsmåde til dannelse af fint pulver
|
|
GB9907658D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Chemical compounds
|
|
CN1355708A
(zh)
|
1999-04-19 |
2002-06-26 |
先灵公司 |
包含利巴韦林与抗氧化剂的hcv联合治疗
|
|
US6924264B1
(en)
|
1999-04-30 |
2005-08-02 |
Amylin Pharmaceuticals, Inc. |
Modified exendins and exendin agonists
|
|
US6291013B1
(en)
|
1999-05-03 |
2001-09-18 |
Southern Biosystems, Inc. |
Emulsion-based processes for making microparticles
|
|
CA2369594A1
(en)
|
1999-05-07 |
2000-11-16 |
Pharmasol Gmbh |
Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
|
|
PT1180121E
(pt)
|
1999-05-17 |
2004-03-31 |
Conjuchem Inc |
Peptidos insulinotropicos de longa duracao
|
|
US6887470B1
(en)
|
1999-09-10 |
2005-05-03 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
US6849714B1
(en)
|
1999-05-17 |
2005-02-01 |
Conjuchem, Inc. |
Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
|
|
US6514500B1
(en)
|
1999-10-15 |
2003-02-04 |
Conjuchem, Inc. |
Long lasting synthetic glucagon like peptide {GLP-!}
|
|
US6506724B1
(en)
|
1999-06-01 |
2003-01-14 |
Amylin Pharmaceuticals, Inc. |
Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus
|
|
AU5936400A
(en)
|
1999-06-04 |
2000-12-28 |
Delrx Pharmaceutical Corporation |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
|
JP2003501375A
(ja)
|
1999-06-04 |
2003-01-14 |
アルザ・コーポレーション |
移植可能なゲル組成物および製造方法
|
|
US20030059376A1
(en)
|
1999-06-04 |
2003-03-27 |
Libbey Miles A. |
Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same
|
|
US20010040326A1
(en)
|
1999-06-14 |
2001-11-15 |
Lord Corporation |
Resilient member with deformed element and method of forming same
|
|
US6833256B1
(en)
|
1999-06-22 |
2004-12-21 |
University Of Maryland |
Interferon tau mutants and methods for making them
|
|
US6528486B1
(en)
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
USD445975S1
(en)
|
1999-08-27 |
2001-07-31 |
Black & Decker, Inc. |
Base unit for a hand held vacuum cleaner
|
|
SE9903236D0
(sv)
|
1999-09-10 |
1999-09-10 |
Astra Ab |
Method to obtain microparticles
|
|
JP2003512052A
(ja)
|
1999-10-15 |
2003-04-02 |
アドバンスド セル テクノロジー、インコーポレイテッド |
分化前駆細胞及び系統欠失胚性幹細胞の産生方法
|
|
US6458387B1
(en)
|
1999-10-18 |
2002-10-01 |
Epic Therapeutics, Inc. |
Sustained release microspheres
|
|
US6284283B1
(en)
|
1999-10-21 |
2001-09-04 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing sub-micron particles of biologically active agents and uses thereof
|
|
US6436091B1
(en)
|
1999-11-16 |
2002-08-20 |
Microsolutions, Inc. |
Methods and implantable devices and systems for long term delivery of a pharmaceutical agent
|
|
US7022674B2
(en)
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
|
WO2001043528A2
(en)
|
1999-12-17 |
2001-06-21 |
Durect Corporation |
Devices and methods in intracerebrospinal delivery of morphine-6-glucuronide
|
|
AU773354B2
(en)
|
1999-12-21 |
2004-05-20 |
Intarcia Therapeutics, Inc. |
Valve for osmotic devices
|
|
US6498193B2
(en)
|
1999-12-22 |
2002-12-24 |
Trustees Of Dartmouth College |
Treatment for complications of type 2 diabetes
|
|
US6283949B1
(en)
|
1999-12-27 |
2001-09-04 |
Advanced Cardiovascular Systems, Inc. |
Refillable implantable drug delivery pump
|
|
US6572890B2
(en)
|
2000-01-13 |
2003-06-03 |
Osmotica Corp. |
Osmotic device containing venlafaxine and an anti-psychotic agent
|
|
US6472060B1
(en)
|
2000-01-19 |
2002-10-29 |
Seco Tools Ab |
Coated body with nanocrystalline CVD coating for enhanced edge toughness and reduced friction
|
|
US6844321B2
(en)
|
2000-01-31 |
2005-01-18 |
Novo Nordisk A/S |
Crystallization of a GLP-1 analogue
|
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
|
US6464688B1
(en)
|
2000-02-15 |
2002-10-15 |
Microsolutions, Inc. |
Osmotic pump delivery system with flexible drug compartment
|
|
US6471688B1
(en)
|
2000-02-15 |
2002-10-29 |
Microsolutions, Inc. |
Osmotic pump drug delivery systems and methods
|
|
CN1487836A
(zh)
|
2000-03-14 |
2004-04-07 |
埃米林药品公司 |
胰高糖素样肽1(7-36)对胃窦幽门十二指肠能动性的影响
|
|
US20030211974A1
(en)
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
|
TWI250874B
(en)
|
2000-03-24 |
2006-03-11 |
Nat Health Research Institutes |
Pharmaceutical compositions for preventing or treating disorders associated with bacterial or viral infection
|
|
JP4361710B2
(ja)
|
2000-04-19 |
2009-11-11 |
ジェネンテック・インコーポレーテッド |
徐放製剤
|
|
EP1278551A2
(en)
|
2000-04-21 |
2003-01-29 |
Vical Incorporated |
Compositions and methods for (in vivo) delivery of polynucleotide-based therapeutics
|
|
AU2001263230B2
(en)
|
2000-05-19 |
2005-03-10 |
Amylin Pharmaceuticals, Llc |
Treatment of acute coronary syndrome with glp-1
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
DE60137876D1
(de)
|
2000-06-16 |
2009-04-16 |
Lilly Co Eli |
Analoge des Glucagon-ähnlichen Peptids-1
|
|
US6479065B2
(en)
|
2000-08-10 |
2002-11-12 |
Alkermes Controlled Therapeutics, Inc. |
Process for the preparation of polymer-based sustained release compositions
|
|
US6547250B1
(en)
|
2000-08-21 |
2003-04-15 |
Westport Research Inc. |
Seal assembly with two sealing mechanisms for providing static and dynamic sealing
|
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
|
US20040115236A1
(en)
|
2000-10-06 |
2004-06-17 |
Chan Tai Wah |
Devices and methods for management of inflammation
|
|
IL155730A0
(en)
|
2000-11-03 |
2003-11-23 |
Biomedicines Inc |
Method for short-term and long-term drug dosimetry
|
|
EP1335704A2
(en)
|
2000-11-16 |
2003-08-20 |
Durect Corporation |
Implant dosage form and use thereof for the delivery of a cholesterol lowering agent
|
|
US20050070883A1
(en)
|
2000-11-29 |
2005-03-31 |
Brown James E |
Devices and methods for controlled delivery from a drug delivery device
|
|
US20020165286A1
(en)
|
2000-12-08 |
2002-11-07 |
Hanne Hedeman |
Dermal anti-inflammatory composition
|
|
AU2002228608A1
(en)
|
2000-12-13 |
2002-06-24 |
Eli Lilly And Company |
Amidated glucagon-like peptide-1
|
|
AU2002239384B2
(en)
|
2000-12-13 |
2007-01-11 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
EP2123293A3
(en)
|
2000-12-14 |
2010-09-08 |
Amylin Pharmaceuticals, Inc. |
Peptide YY and petide YY agonists for treatment of metabolic disorders
|
|
AU2002232824A1
(en)
|
2000-12-21 |
2002-07-01 |
Inhale Therapeutic Systems, Inc. |
Induced phase transition method for the production of microparticles containing hydrophobic active agents
|
|
USD472896S1
(en)
|
2000-12-23 |
2003-04-08 |
Andreas Peiker |
Telephone support
|
|
IN188924B
(enExample)
|
2001-03-01 |
2002-11-23 |
Bharat Serums & Vaccines Ltd |
|
|
WO2002076344A1
(en)
|
2001-03-23 |
2002-10-03 |
Durect Corporation |
Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space
|
|
US6632217B2
(en)
|
2001-04-19 |
2003-10-14 |
Microsolutions, Inc. |
Implantable osmotic pump
|
|
JP2005506956A
(ja)
|
2001-06-01 |
2005-03-10 |
イーライ・リリー・アンド・カンパニー |
長時間作用性ｇｌｐ−１製剤
|
|
US6514517B2
(en)
|
2001-06-20 |
2003-02-04 |
Ethicon, Inc. |
Antimicrobial coatings for medical devices
|
|
PT1397155E
(pt)
|
2001-06-21 |
2015-12-07 |
Genentech Inc |
Formulação de libertação sustentada
|
|
US7163688B2
(en)
|
2001-06-22 |
2007-01-16 |
Alza Corporation |
Osmotic implant with membrane and membrane retention means
|
|
EP1401503B1
(en)
|
2001-06-22 |
2007-05-09 |
Pfizer Products Inc. |
Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer
|
|
AU2002322289A1
(en)
|
2001-06-22 |
2003-01-08 |
Johns Hopkins University School Of Medicine |
Biodegradable polymer coompositions
|
|
US20030138403A1
(en)
|
2001-06-29 |
2003-07-24 |
Maxygen Aps |
Interferon formulations
|
|
CN1549724A
(zh)
|
2001-07-20 |
2004-11-24 |
����ͨѶ�ɷ�����˾ |
治疗肝纤维化的方法
|
|
EP1411968B1
(en)
|
2001-07-31 |
2008-09-17 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Glp-1 exendin-4 peptide analogs and uses thereof
|
|
AU2002322403A1
(en)
|
2001-08-23 |
2003-03-10 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
GB0121709D0
(en)
|
2001-09-07 |
2001-10-31 |
Imp College Innovations Ltd |
Food inhibition agent
|
|
CA2460334A1
(en)
|
2001-09-14 |
2003-03-27 |
Francis J. Martin |
Microfabricated nanopore device for sustained release of therapeutic agent
|
|
EP1435919B1
(en)
|
2001-09-17 |
2009-09-23 |
Durect Corporation |
Device and method for accurate delivery of an active agent
|
|
ES2320979T3
(es)
|
2001-09-24 |
2009-06-01 |
Imperial Innovations Limited |
Pyy-36 para la reduccion o prevencion de la obesidad.
|
|
US7041646B2
(en)
|
2001-10-05 |
2006-05-09 |
Bayer Pharmaceuticals Corporation |
Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists
|
|
BR0213103A
(pt)
|
2001-10-05 |
2004-09-21 |
Intermune Inc |
Método para tratamento de infecção pelo vìrus da hepatite com um perfil de liberação de interferon multifásico
|
|
EP2226043B1
(en)
|
2001-10-24 |
2014-12-31 |
MED-EL Elektromedizinische Geräte GmbH |
Implantable fluid delivery apparatus and implantable electrode
|
|
US20040142902A1
(en)
|
2001-11-08 |
2004-07-22 |
Struijker- Boudier Harry A.J. |
Implant dosage form and use thereof for the delivery of a cholosterol lowering agent
|
|
IL161889A0
(en)
|
2001-11-09 |
2005-11-20 |
Biomedicines Inc |
Method for treating diseases with omega interferon
|
|
NZ533434A
(en)
|
2001-11-14 |
2006-11-30 |
Alza Corp |
Thixotropic gel composition for injectable deposition
|
|
AU2002359407B2
(en)
|
2001-11-14 |
2008-02-28 |
Durect Corporation |
Catheter injectable depot compositions and uses thereof
|
|
ATE507816T1
(de)
|
2001-11-14 |
2011-05-15 |
Durect Corp |
Injizierbare depotzusammensetzungen und deren verwendung
|
|
DE10159217A1
(de)
|
2001-11-27 |
2003-06-05 |
Schering Ag |
17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
|
|
US20030108608A1
(en)
|
2001-12-12 |
2003-06-12 |
Erik Laridon |
Thermoplastic articles comprising silver-containing antimicrobials and high amounts of carboxylic acid salts for increased surface-available silver
|
|
US20030232078A1
(en)
|
2001-12-19 |
2003-12-18 |
Dong Liang C. |
Formulation & dosage form for the controlled delivery of therapeutic agents
|
|
CA2841097A1
(en)
|
2001-12-21 |
2003-07-24 |
Human Genome Sciences, Inc. |
Albumin and g-csf fusion proteins
|
|
US8058233B2
(en)
|
2002-01-10 |
2011-11-15 |
Oregon Health And Science University |
Modification of feeding behavior using PYY and GLP-1
|
|
US7105489B2
(en)
|
2002-01-22 |
2006-09-12 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for treating polycystic ovary syndrome
|
|
NZ535008A
(en)
|
2002-02-08 |
2005-09-30 |
Alkermes Inc |
Polymer-based compositions for sustained release
|
|
US7635463B2
(en)
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
US20050260259A1
(en)
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
AU2003219922B2
(en)
|
2002-02-27 |
2009-09-10 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
GB0204722D0
(en)
|
2002-02-28 |
2002-04-17 |
Norferm Da |
Method
|
|
GB2386066A
(en)
|
2002-02-28 |
2003-09-10 |
Norbrook Lab Ltd |
Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
|
|
JP2006512102A
(ja)
|
2002-04-11 |
2006-04-13 |
メディミューン・ヴァクシンズ・インコーポレーテッド |
噴霧乾燥による生物活性材料の防腐
|
|
PT2561860T
(pt)
|
2002-05-31 |
2018-05-08 |
Titan Pharmaceuticals Inc |
Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
|
|
WO2003105803A1
(en)
|
2002-06-17 |
2003-12-24 |
Alza Corporation |
Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
WO2004002565A1
(en)
|
2002-06-26 |
2004-01-08 |
Alza Corporation |
Minimally compliant, volume efficient piston for osmotic drug delivery systems
|
|
US7177526B2
(en)
|
2002-06-28 |
2007-02-13 |
Intel Corporation |
System and method for improving audio during post-production of video recordings
|
|
CN1684663A
(zh)
|
2002-07-31 |
2005-10-19 |
阿尔萨公司 |
可注射的多模式聚合物储库组合物以及其用途
|
|
WO2004012703A1
(en)
|
2002-07-31 |
2004-02-12 |
Alza Corporation |
Injectable depot compositions and uses thereof
|
|
US20080260838A1
(en)
|
2003-08-01 |
2008-10-23 |
Mannkind Corporation |
Glucagon-like peptide 1 (glp-1) pharmaceutical formulations
|
|
AU2003267327A1
(en)
|
2002-09-04 |
2004-03-29 |
Ruark Botha |
Device for securing a blood vessel cannula to a body
|
|
AU2003282955A1
(en)
|
2002-10-17 |
2004-05-04 |
Alkermes Controlled Therapeutics, Inc. Ii |
Microencapsulation and sustained release of biologically active polypeptides
|
|
EP1567127A4
(en)
|
2002-10-17 |
2007-02-21 |
Alkermes Inc |
METHOD FOR MODIFYING THE RELEASE PROFILE OF COMPRESSED RELATED COMPOSITION COMPOSITIONS
|
|
MXPA05004202A
(es)
|
2002-10-22 |
2005-09-20 |
Waratah Pharmaceuticals Inc |
Tratamiento de la diabetes.
|
|
US7368126B2
(en)
|
2002-11-06 |
2008-05-06 |
Guohua Chen |
Controlled release depot formulations
|
|
US6969702B2
(en)
|
2002-11-20 |
2005-11-29 |
Neuronova Ab |
Compounds and methods for increasing neurogenesis
|
|
US7014636B2
(en)
|
2002-11-21 |
2006-03-21 |
Alza Corporation |
Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
|
|
US7790681B2
(en)
|
2002-12-17 |
2010-09-07 |
Amylin Pharmaceuticals, Inc. |
Treatment of cardiac arrhythmias with GLP-1 receptor ligands
|
|
KR20050088196A
(ko)
|
2002-12-19 |
2005-09-02 |
알자 코포레이션 |
안정한 비수성 단일 상 겔 및 이식가능한 장치로부터전달하기 위한 이의 제형
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
GB0300571D0
(en)
|
2003-01-10 |
2003-02-12 |
Imp College Innovations Ltd |
Modification of feeding behaviour
|
|
JP2004238392A
(ja)
|
2003-01-14 |
2004-08-26 |
Nipro Corp |
安定化された蛋白質性製剤
|
|
JP2006518093A
(ja)
|
2003-02-18 |
2006-08-03 |
メドコンクス， インコーポレイテッド |
摩擦嵌め設計の雄型医療装置用電気コネクタ関連出願本出願は、２００３年２月１８日に出願の「汎用コネクタシステムの作成も可能な環状雄型コネクタの嵌合及び鎖錠方法」（ＡＭｅｔｈｏｄｆｏｒＦｉｔｔｉｎｇａｎｄＬａｔｃｈｉｎｇＣｉｒｃｕｌａｒＭａｌｅＣｏｎｎｅｃｔｏｒｓＷｈｉｃｈＡｌｓｏＥｎａｂｌｅｓＣｒｅａｔｉｏｎｏｆａＵｎｉｖｅｒｓａｌＣｏｎｎｅｃｔｏｒＳｙｓｔｅｍ）と題する米国特許仮出願第６０／４４８５１７号の合衆国特許法第１１９条に基づく優先権の利益を主張するものである。
|
|
JP2006521898A
(ja)
|
2003-03-31 |
2006-09-28 |
アルザ・コーポレーション |
浸透送り出しシステム及び浸透送り出しシステムの始動時間を短縮する方法
|
|
US7207982B2
(en)
|
2003-03-31 |
2007-04-24 |
Alza Corporation |
Osmotic pump with means for dissipating internal pressure
|
|
RU2005133427A
(ru)
|
2003-03-31 |
2006-04-27 |
Алза Корпорейшн (Us) |
Безводные однофазные носители и препараты с использованием таких носителей
|
|
JP2007504920A
(ja)
|
2003-05-16 |
2007-03-08 |
ブルー メンブレーンス ゲーエムベーハー |
生体適合性コーティングされた医療用インプラント
|
|
US20040247672A1
(en)
|
2003-05-16 |
2004-12-09 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
|
US8008255B2
(en)
|
2003-05-30 |
2011-08-30 |
Amylin Pharmaceuticals, Inc. |
Methods and compositions for enhanced transmucosal delivery of peptides and proteins
|
|
US20050079202A1
(en)
|
2003-05-30 |
2005-04-14 |
Guohua Chen |
Implantable elastomeric depot compositions and uses thereof
|
|
KR101308912B1
(ko)
|
2003-06-03 |
2013-09-23 |
노보 노르디스크 에이/에스 |
안정화된 약학적 펩티드 조성물
|
|
US8491571B2
(en)
|
2003-06-12 |
2013-07-23 |
Cordis Corporation |
Orifice device having multiple channels with varying flow rates for drug delivery
|
|
US7454765B2
(en)
|
2003-07-09 |
2008-11-18 |
Samsung Electronics Co., Ltd. |
Optical disc drive
|
|
US7205409B2
(en)
|
2003-09-04 |
2007-04-17 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
US9005244B2
(en)
|
2003-09-30 |
2015-04-14 |
Ethicon, Inc. |
Tissue approximation device
|
|
BRPI0414941A
(pt)
|
2003-09-30 |
2006-11-07 |
Alza Corp |
dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente
|
|
WO2005044239A2
(en)
|
2003-10-31 |
2005-05-19 |
Alza Corporation |
Osmotic pump with self-retaining, fast-start membrane plug
|
|
KR20060121890A
(ko)
|
2003-11-06 |
2006-11-29 |
알자 코포레이션 |
이식형 삼투 펌프와 함께 사용하기 위한 모듈식 흡수율감소기
|
|
US20050281879A1
(en)
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US20050106214A1
(en)
|
2003-11-14 |
2005-05-19 |
Guohua Chen |
Excipients in drug delivery vehicles
|
|
US20050118206A1
(en)
|
2003-11-14 |
2005-06-02 |
Luk Andrew S. |
Surfactant-based gel as an injectable, sustained drug delivery vehicle
|
|
US7780973B2
(en)
|
2003-12-15 |
2010-08-24 |
Ethicon Endo-Surgery, Inc. |
Method and device for minimally invasive implantation of biomaterial
|
|
US20050216087A1
(en)
|
2004-01-05 |
2005-09-29 |
St. Francis Medical Technologies, Inc. |
Disk repair structures for positioning disk repair material
|
|
US20050175701A1
(en)
|
2004-02-10 |
2005-08-11 |
Alza Corporation |
Capillary moderator for osmotic delivery system
|
|
US8076288B2
(en)
|
2004-02-11 |
2011-12-13 |
Amylin Pharmaceuticals, Inc. |
Hybrid polypeptides having glucose lowering activity
|
|
KR20140011431A
(ko)
|
2004-02-11 |
2014-01-28 |
아밀린 파마슈티칼스, 엘엘씨. |
선택가능한 특성을 갖는 하이브리드 폴리펩티드
|
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
|
CN1968700A
(zh)
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
|
US20050266087A1
(en)
|
2004-05-25 |
2005-12-01 |
Gunjan Junnarkar |
Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
|
|
JP2008504249A
(ja)
|
2004-06-28 |
2008-02-14 |
ノボ ノルディスク アクティーゼルスカブ |
糖尿病を治療するための方法
|
|
US7772182B2
(en)
|
2004-08-05 |
2010-08-10 |
Alza Corporation |
Stable suspension formulations of erythropoietin receptor agonists
|
|
WO2006023526A2
(en)
|
2004-08-18 |
2006-03-02 |
Waters Investments Limited |
Defined leak path for high pressure seal
|
|
US8268791B2
(en)
|
2004-08-25 |
2012-09-18 |
Aegis Therapeutics, Llc. |
Alkylglycoside compositions for drug administration
|
|
US20060094693A1
(en)
|
2004-09-21 |
2006-05-04 |
Point Therapeutics, Inc. |
Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
MX2007003968A
(es)
|
2004-10-01 |
2008-03-04 |
Ramscor Inc |
Composiciones de farmaco de liberacion sostenida convenientemente implantables.
|
|
US7442682B2
(en)
|
2004-10-19 |
2008-10-28 |
Nitto Denko Corporation |
Transepithelial delivery of peptides with incretin hormone activities
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
DK1814590T4
(da)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals Llc |
Behandling af obesitet og beslægtede sygdomme.
|
|
US7575579B2
(en)
|
2004-11-18 |
2009-08-18 |
Union Surgical, Llc |
Drill guide tissue protector
|
|
US20060142234A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
|
US20060141040A1
(en)
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
|
WO2006074051A2
(en)
|
2004-12-30 |
2006-07-13 |
Diakine Therapeutics, Inc. |
PHARMACEUTICAL COMPOSITIONS AND METHODS FOR RESTORING β-CELL MASS AND FUNCTION
|
|
USD587374S1
(en)
|
2005-01-14 |
2009-02-24 |
Edwards Lifesciences Corporation |
Sensor case
|
|
CA2593848C
(en)
|
2005-01-24 |
2012-08-07 |
N.V. Organon |
Applicator for inserting an implant
|
|
AU2006208131A1
(en)
|
2005-01-25 |
2006-08-03 |
Microchips, Inc. |
Control of drug release by transient modification of local microenvironments
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
EP1877077A2
(en)
|
2005-02-03 |
2008-01-16 |
Intarcia Therapeutics, Inc. |
An implantable interferon-containing device
|
|
US20060216242A1
(en)
|
2005-02-03 |
2006-09-28 |
Rohloff Catherine M |
Suspending vehicles and pharmaceutical suspensions for drug dosage forms
|
|
US20070032420A1
(en)
|
2005-02-09 |
2007-02-08 |
Entelos, Inc. |
Treating diabetes with glucagon-like peptide-1 secretagogues
|
|
CA2597649A1
(en)
|
2005-02-11 |
2006-08-17 |
Amylin Pharmaceuticals, Inc. |
Gip analog and hybrid polypeptides with selectable properties
|
|
US8263545B2
(en)
|
2005-02-11 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
GIP analog and hybrid polypeptides with selectable properties
|
|
GB0504857D0
(en)
|
2005-03-09 |
2005-04-13 |
Imp College Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
US7959938B2
(en)
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
KR20080003849A
(ko)
|
2005-03-31 |
2008-01-08 |
아밀린 파마슈티칼스, 인크. |
비만 및 섭식 장애의 조절, 예방 및 치료를 위한 조성물 및방법
|
|
EP1909824B1
(en)
|
2005-04-08 |
2011-05-18 |
Amylin Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising incretin peptide and aprotic polar solvent
|
|
JP2008536881A
(ja)
|
2005-04-21 |
2008-09-11 |
ガストロテック・ファルマ・アクティーゼルスカブ |
Ｇｌｐ−１分子と制吐剤との医薬製剤
|
|
US7686787B2
(en)
|
2005-05-06 |
2010-03-30 |
Medtronic Minimed, Inc. |
Infusion device and method with disposable portion
|
|
PL1888031T3
(pl)
|
2005-06-06 |
2013-04-30 |
Camurus Ab |
Preparaty analogu glp-1
|
|
US20060280795A1
(en)
|
2005-06-08 |
2006-12-14 |
Dexcel Pharma Technologies, Ltd. |
Specific time-delayed burst profile delivery system
|
|
GB2442396B
(en)
|
2005-07-22 |
2011-05-11 |
Univ Utah Res Found |
Osmotically driven dispense pump and related components for use in high pressure applications
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
EP1922336B1
(en)
|
2005-08-11 |
2012-11-21 |
Amylin Pharmaceuticals, LLC |
Hybrid polypeptides with selectable properties
|
|
US8389472B2
(en)
|
2005-08-19 |
2013-03-05 |
Amylin Pharmaceuticals, Llc |
Exendin-4 to treat nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
|
|
PL2347762T3
(pl)
|
2005-08-19 |
2019-09-30 |
Amylin Pharmaceuticals, Llc |
Eksendyna do leczenia cukrzycy i zmniejszania masy ciała
|
|
PL1965823T3
(pl)
|
2005-11-04 |
2017-08-31 |
Glaxosmithkline Llc |
Sposoby podawania środków hipoglikemicznych
|
|
US8039432B2
(en)
|
2005-11-09 |
2011-10-18 |
Conjuchem, Llc |
Method of treatment of diabetes and/or obesity with reduced nausea side effect
|
|
AU2006329836A1
(en)
|
2005-12-16 |
2007-07-05 |
Amylin Pharmaceuticals, Llc |
Compositions and methods for treating obesity and related metabolic disorders
|
|
WO2007075534A2
(en)
|
2005-12-16 |
2007-07-05 |
Nektar Therapeutics Al, Corporation |
Polymer conjugates of glp-1
|
|
CA2637569C
(en)
|
2006-01-18 |
2013-01-08 |
Yuhua Li |
Pharmaceutical compositions with enhanced stability
|
|
AU2007227202B2
(en)
|
2006-03-21 |
2013-08-22 |
Amylin Pharmaceuticals, Llc |
Peptide-peptidase inhibitor conjugates and methods of using same
|
|
EP3255149A3
(en)
|
2006-05-02 |
2018-04-18 |
Intrexon Actobiotics NV |
Microbial intestinal delivery of obesity related peptides
|
|
EP2029160A2
(en)
|
2006-05-12 |
2009-03-04 |
Amylin Pharmaceuticals, Inc. |
Methods to restore glycemic control
|
|
EP2020990B1
(en)
|
2006-05-30 |
2010-09-22 |
Intarcia Therapeutics, Inc |
Two-piece, internal-channel osmotic delivery system flow modulator
|
|
GB0613196D0
(en)
|
2006-07-03 |
2006-08-09 |
Imp Innovations Ltd |
Novel compounds and their effects on feeding behaviour
|
|
EP2054073B1
(en)
|
2006-07-11 |
2014-11-26 |
Foresee Pharmaceuticals, Inc. |
Pharmaceutical compositions for sustained release delivery of peptides
|
|
EP2066337A2
(en)
|
2006-08-04 |
2009-06-10 |
Amylin Pharmaceuticals, Inc. |
Use of exendins, exendin agonists and glp-1 receptor agonists for altering the concentration of fibrinogen
|
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
|
US20100098735A1
(en)
|
2006-10-05 |
2010-04-22 |
Rajesh Jain |
Injectable depot compositions and its process of preparation
|
|
WO2008061355A1
(en)
|
2006-11-24 |
2008-05-29 |
Matregen Corp. |
Glp-1 depot systems, and methods of manufacture and uses thereof
|
|
TWI428346B
(zh)
|
2006-12-13 |
2014-03-01 |
Imp Innovations Ltd |
新穎化合物及其等對進食行為影響
|
|
USD555589S1
(en)
|
2007-01-23 |
2007-11-20 |
Intec, Inc. |
Battery charger and game controller cradle
|
|
WO2008092084A2
(en)
|
2007-01-26 |
2008-07-31 |
Centocor, Inc. |
Injectable non-aqueous suspension with high concentration of therapeutic agent
|
|
EP1958576A3
(en)
|
2007-02-13 |
2009-08-05 |
Arthrex Inc |
Double cut shaver
|
|
US8262667B1
(en)
|
2007-02-23 |
2012-09-11 |
Holmed Corporation |
Multi-diameter implant forceps
|
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
US8236760B2
(en)
|
2007-04-27 |
2012-08-07 |
Cedars-Sinsai Medical Center |
Use of GLP-1 receptor agonists for the treatment of short bowel syndrome
|
|
EP2254559B1
(en)
|
2008-02-08 |
2018-10-10 |
Foresee Pharmaceuticals Co., Ltd. |
Composition for sustained release delivery of proteins or peptides
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
AU2009214632B2
(en)
|
2008-02-14 |
2015-02-19 |
Reshape Lifesciences, Inc. |
Treatment of excess weight by neural downregulation in combination with compositions
|
|
EP2259791A2
(en)
|
2008-03-05 |
2010-12-15 |
Tel HaShomer Medical Research Infrastructure and Services Ltd. |
Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
|
|
WO2009109921A1
(en)
|
2008-03-05 |
2009-09-11 |
Grant Pierre Van Antwerp |
A clamp device
|
|
US20090234392A1
(en)
|
2008-03-13 |
2009-09-17 |
Depuy Spine, Inc. |
Method for inserting a spinal fixation element using implants having guide tabs
|
|
US8377881B2
(en)
|
2008-04-01 |
2013-02-19 |
MosaMedix B. V. |
Compositions and methods for reducing scar formation in wound healing
|
|
CN105031811B
(zh)
|
2008-04-04 |
2017-09-08 |
安特罗麦迪克斯公司 |
用于葡萄糖调节的方法和系统
|
|
ES2552646T3
(es)
|
2008-05-21 |
2015-12-01 |
Amylin Pharmaceuticals, Inc. |
Exendinas para disminuir el colesterol y los triglicéridos
|
|
TWI541023B
(zh)
*
|
2008-06-17 |
2016-07-11 |
印第安納大學科技研究公司 |
在生理ｐｈ緩衝液中呈現增強之溶解度及穩定性之升糖激素類似物
|
|
RU2678833C2
(ru)
|
2008-09-17 |
2019-02-04 |
Киазма Инк. |
Фармацевтические композиции и соответствующие способы доставки
|
|
KR101707791B1
(ko)
|
2008-09-30 |
2017-02-17 |
엔도 파마슈티컬즈, 솔루션스 아이엔씨. |
리스페리돈 전달용 이식형 장치
|
|
CN104013569A
(zh)
|
2008-10-15 |
2014-09-03 |
精达制药公司 |
高浓缩药物颗粒、制剂、混悬剂及其应用
|
|
EP2367503A1
(en)
|
2008-11-25 |
2011-09-28 |
AttenueX Technologies, Inc. |
Implant with high vapor pressure medium
|
|
US20100298840A1
(en)
|
2009-05-22 |
2010-11-25 |
Schwartz Lyman D |
Phimosis Treatment Device and Method
|
|
WO2010148089A1
(en)
*
|
2009-06-16 |
2010-12-23 |
Indiana University Research And Technology Corporation |
Gip receptor-active glucagon compounds
|
|
USD638478S1
(en)
|
2009-07-06 |
2011-05-24 |
Performance Designed Products Llc |
Video game controller accessory
|
|
US20110022165A1
(en)
|
2009-07-23 |
2011-01-27 |
Edwards Lifesciences Corporation |
Introducer for prosthetic heart valve
|
|
US9358064B2
(en)
|
2009-08-07 |
2016-06-07 |
Ulthera, Inc. |
Handpiece and methods for performing subcutaneous surgery
|
|
USD789539S1
(en)
|
2015-07-09 |
2017-06-13 |
Spinal Surgical Strategies, Llc |
Fusion cage
|
|
EP3323423B1
(en)
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
US20120329711A1
(en)
|
2009-12-16 |
2012-12-27 |
Nordisk A/S |
Glp-1 receptor agonist compounds with a modified n-terminus
|
|
JO2976B1
(en)
|
2009-12-22 |
2016-03-15 |
ايلي ليلي اند كومباني |
Axentomodulin polypeptide
|
|
AR079344A1
(es)
|
2009-12-22 |
2012-01-18 |
Lilly Co Eli |
Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
|
|
US8263554B2
(en)
|
2010-06-09 |
2012-09-11 |
Amylin Pharmaceuticals, Inc. |
Methods of using GLP-1 receptor agonists to treat pancreatitis
|
|
USD669589S1
(en)
|
2010-08-31 |
2012-10-23 |
Koninklijke Philips Electronics N.V. |
Blood system cartridge
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
WO2013004983A1
(en)
*
|
2011-07-04 |
2013-01-10 |
Imperial Innovations Limited |
Novel compounds and their effects on feeding behaviour
|
|
US20130098928A1
(en)
|
2011-09-16 |
2013-04-25 |
Golden Aluminum, Inc. |
Application of designs to portion of food container
|
|
TWD149032S
(zh)
|
2011-10-04 |
2012-09-01 |
虹光精密工業股份有限公司 |
手持式掃描器底座
|
|
BR112014007124A2
(pt)
*
|
2011-11-17 |
2017-06-13 |
Univ Indiana Res & Tech Corp |
superfamília de peptídeos gluxagon que exibem atividade no receptor glicocorticóide
|
|
ES2699655T3
(es)
|
2012-04-19 |
2019-02-12 |
Removaid As |
Herramienta para extraer un artículo implantado bajo la piel
|
|
EP2856940B1
(en)
|
2012-05-29 |
2020-05-06 |
National University Corporation Kochi University |
Artery imaging device, and artery visualization device and method
|
|
US20140058425A1
(en)
|
2012-08-27 |
2014-02-27 |
Amir Porat |
Manually operated surgical devices with operative portions formed of a see-through material
|
|
US9332995B2
(en)
|
2012-09-25 |
2016-05-10 |
Russo Inventions, Llc |
Bone-harvesting tool
|
|
US9241722B2
(en)
|
2012-10-08 |
2016-01-26 |
Warsaw Orthopedic, Inc. |
Surgical pin guide and methods of use
|
|
US20150297509A1
(en)
|
2012-11-19 |
2015-10-22 |
Braeburn Pharmaceuticals Bvba Sprl |
Implantable drug delivery compositions and methods of treatment thereof
|
|
US20160058881A1
(en)
*
|
2013-03-15 |
2016-03-03 |
Indiana University Research And Technology Corporation |
Prodrugs with prolonged action
|
|
USD731630S1
(en)
|
2014-04-08 |
2015-06-09 |
Bootz Manufacturing Company |
Shower pan
|
|
JP6217521B2
(ja)
|
2014-05-21 |
2017-10-25 |
トヨタ自動車株式会社 |
燃料電池システム及びその制御方法
|
|
USD724740S1
(en)
|
2014-06-05 |
2015-03-17 |
Deka Products Limited Partnership |
Enclosure for a peritoneal dialysis device
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
USD769540S1
(en)
|
2015-03-19 |
2016-10-18 |
Safer Sports Technologies |
Protective head guard insert
|
|
ES2968262T3
(es)
|
2015-06-03 |
2024-05-08 |
I2O Therapeutics Inc |
Sistemas de colocación de implantes
|
|
USD789540S1
(en)
|
2016-01-29 |
2017-06-13 |
Veterinary Implants Direct, Llc. |
Orthopedic plate
|
|
JP6594797B2
(ja)
|
2016-02-26 |
2019-10-23 |
エイブリック株式会社 |
スイッチングレギュレータ
|
|
US9931133B2
(en)
|
2016-03-24 |
2018-04-03 |
A.M. Surgical, Inc. |
Compact endoscopic surgical device and method of use thereof
|
|
KR20240037175A
(ko)
*
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
